ESC Premium Access

Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF

Presentation

About the speaker

Doctor Soeren Lund Kristensen

Gentofte Hospital - Copenhagen University Hospital, Department of Cardiology, Hellerup (Denmark)
0 follower

7 more presentations in this session

Diagnostic usefulness of passive leg raising test for detection of heart failure with preserved ejection fraction compared to cycle ergometer exercise(invasive hemodynamic study)

Speaker: Associate Professor S. Hwang (Jinju, KR)

Thumbnail

Impact of catheter ablation on HFpEF in people with comorbid atrial fibrillation and HFpEF using invasive haemodynamic testing.

Speaker: Doctor H. Sugumar (Melbourne, AU)

Thumbnail

Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction

Speaker: Doctor A. Sayour (Budapest, HU)

Thumbnail

Effect of sacubitril/valsartan on cognitive function in patients with HFpEF: A prespecified analysis of PARAGON-HF

Speaker: Doctor P. Dewan (Glasgow, GB)

Thumbnail

Sex-specific effect of obesity on exercise capacity and diastolic function

Speaker: Doctor M. Jung (Hwaseong-si, KP)

Thumbnail

Access the full session

Mechanisms of Heart Failure and Implications for Clinical Translation

Speakers: Doctor S. Kristensen, Associate Professor S. Hwang, Doctor H. Sugumar, Doctor A. Sayour, Doctor P. Dewan...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Definition and pathophysiological mechanisms of HFpEF.

29 August 2021

Open Access

New recommendations for comorbidities.

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

This platform is supported by

logo Novo Nordisk